Patents by Inventor Stephane Rioux

Stephane Rioux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Group B antigens and corresponding DNA fragments
    Patent number: 7393536
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: July 1, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stéphane Rioux, Bernard R. Brodeur, Josée Hamel, Martine Boyer
  • BVH-A2 and BVH-A3 antigens of group B
    Patent number: 7335368
    Abstract: Group B streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: February 26, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stephane Rioux, Martine Boyer, Josée Hamel, Bernard R Brodeur
  • Streptococcus Pyogenes Antigens
    Publication number: 20080038268
    Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: July 9, 2007
    Publication date: February 14, 2008
    Applicant: ID Biomedical Corporation
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
  • () polypeptides and corresponding DNA fragments
    Patent number: 7329500
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamela) catarrhalis which may be used for prophy-laxis, diagnostic and/or therapy purposes.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: February 12, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josée Hamel, Bernard R. Brodeur, Stéphane Rioux, Julie Couture
  • Group b streptococcus antigens
    Publication number: 20070275004
    Abstract: The present invention relates to polypeptides, epitopes and antibodies directed to these epitopes, more particularly to the Sip polypeptide of Group B streptococcus (GBS), also called Streptococcus Agalactiae which may be used to prevent, diagnose and/or treat streptococcal infection.
    Type: Application
    Filed: February 11, 2003
    Publication date: November 29, 2007
    Inventors: Stephane Rioux, Denis Martin, Josee Hamel, Bernard Brodeur
  • antigens
    Patent number: 7247308
    Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pygenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: July 24, 2007
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
  • Polypeptides of streptococcus pyogenes
    Publication number: 20070110763
    Abstract: The present invention relates to polypeptides of S. pyogenes which may be useful to prevent, diagnose and/or treat S. pyogenes infections.
    Type: Application
    Filed: August 16, 2004
    Publication date: May 17, 2007
    Inventors: Stephane Rioux, Denis Martin, Josee Hamel, Bernard Brodeur, Patrick Rheault, Nathalie Drouin
  • Pharmaceutical compositions
    Publication number: 20070014841
    Abstract: The present invention relates to polypeptides, epitopes and antibodies directed to these epitopes, more particularly to the Sip polypeptide of Group B Streptococcus (GBS), also called Streptococcus agalactiae which may be used to prevent, diagnose and/or treat streptococcal infection.
    Type: Application
    Filed: February 8, 2006
    Publication date: January 18, 2007
    Inventors: Denis Martin, Stephane Rioux
  • Pharmaceutical liposomal compositions
    Publication number: 20070014842
    Abstract: Pharmaceutical compositions comprising a liposome associated to N. meningitidis polypeptides fragments or analogs thereof or corresponding DNA fragments, can be used to prevent, diagnose and/or treat neisserial infections.
    Type: Application
    Filed: March 7, 2006
    Publication date: January 18, 2007
    Inventors: Denis Martin, Stephane Rioux
  • Moraxella (branhamella) catarrhalis antigens
    Publication number: 20050080233
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamella) catarrhalis which may be useful for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: June 18, 2002
    Publication date: April 14, 2005
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Genevieve Leblanc, Julie Couture
  • Polypeptides of moraxella (branhamella) catarrhalis
    Publication number: 20050070691
    Abstract: The present invention relates to polypeptides, more particularly polypeptides of Moraxella (Branhamella) catarrhalis which may be used to prevent, diagnose and/or treat Moraxella (Branhamella) catarrhalis infection.
    Type: Application
    Filed: November 15, 2002
    Publication date: March 31, 2005
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Julie Couture
  • Group b streptococcus antigens and corresponding dna fragments
    Publication number: 20040242844
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: July 16, 2004
    Publication date: December 2, 2004
    Inventors: Denis Martin, Stephane Rioux, Bernard Brodeur, Josee Hamel, Martine Boyer
  • Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
    Publication number: 20040242859
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamela) catarrhalis wich may be used for prophy-laxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: February 26, 2004
    Publication date: December 2, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Julie Couture
  • Moraxella(branhamella) catarrhalis antigens
    Publication number: 20040236087
    Abstract: The present invention relates to polypeptides of Moraxella(Branhamella) calarrhalis which may be useful for prophylaxis, diagnosis and/or therapy purposes.
    Type: Application
    Filed: June 2, 2004
    Publication date: November 25, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard R. Brodeur, Stephane Rioux, Julie Couture
  • Antigens of group b streptococcus and corresponding dna fragments
    Publication number: 20040171113
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: April 19, 2004
    Publication date: September 2, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard R Brodeur, Stephane Rioux, Martine Boyer
  • Pharmaceutical compositions
    Publication number: 20040132652
    Abstract: Pharmaceutical compositions comprising a liposome associated to N. meningitidis polypeptides fragments or analogs thereof or corresponding DNA fragments, can be used to prevent, diagnose and/or treat neisserial infections.
    Type: Application
    Filed: August 28, 2003
    Publication date: July 8, 2004
    Applicant: Shire BioChem Inc.
    Inventors: Denis Martin, Stephane Rioux
  • Streptococcus pyogenes antigens and corresponding dna fragments
    Publication number: 20040097706
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: November 18, 2003
    Publication date: May 20, 2004
    Inventors: Denis Martin, Bernard Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • Bvh-a2 and bvh-a3 antigens of group b streptococcus
    Publication number: 20040071730
    Abstract: Group B streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
    Type: Application
    Filed: September 26, 2003
    Publication date: April 15, 2004
    Inventors: Denis Martin, Stephane Rioux, Martine Boyer, Josee HAmel, Bernard Brodeur
  • Streptococcus pyogenes antigens
    Publication number: 20030165528
    Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pygenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: April 22, 2003
    Publication date: September 4, 2003
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
  • Streptococcus pyogenes polypeptides and corresponding DNA fragments
    Publication number: 20030049271
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for prophylaxis, therapy and/or diagnostic.
    Type: Application
    Filed: February 21, 2002
    Publication date: March 13, 2003
    Applicant: Shire BioChem Inc.
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Patrick Rheault